US FDA approves Bristol Myers' blood cancer treatment

By Sneha S K and Siddhi Mahatole Aug 13 (Reuters) - The U.S. FDA on Thursday approved Bristol Myers Squibb's oral combination ...

Bristol Myers Squibb to build $2.3B advanced manufacturing plant in Houston, creating 500 jobs

Bristol Myers Squibb will build a massive advanced manufacturing and life sciences facility in Houston's Generation Park, ...

AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'

The companies have discussed a potential merger over several months, reports say.

Lawsuit against Bristol Myers over delayed cancer drug is revived

By Jonathan Stempel NEW YORK, Aug 13 (Reuters) - A U.S. federal appeals court said a judge erred in dismissing a $6.7 billion lawsuit accusing Bristol Myers Squibb of cheating former Celgene ...
Morningstar

Bristol Myers Squibb Gets FDA Approval for Myeloma Treatment

Bristol Myers Squibb received approval for Zenbexus to be used as a treatment for multiple myeloma when combined with certain other drugs. The biopharmaceutical manufacturer said Thursday the Food ...

Is the reported $400 billion AstraZeneca-Bristol Myers Squibb megamerger a slam dunk or a disaster waiting to happen?

There's a good reason why AstraZeneca tanked when merger rumors hit the Street.
Hosted on MSN

Cytokinetics sues Bristol-Myers to avoid patent case

Cytokinetics (CYTK) on Thursday disclosed a lawsuit against Bristol-Myers Squibb (BMY) and its 2020 buyout, MyoKardia, to avoid a potential patent infringement case related to its heart disease ...